Jaguar Health, Inc.
Ticker: 1585608
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 20.27+558.1% | 3.08+3.4% | 2.98+34.8% | 2.21-28.9% | 3.11 |
| Total Income | 20.27+558.1% | 3.08+3.4% | 2.98+34.8% | 2.21-28.9% | 3.11 |
| EXPENSES | |||||
| Expenditure | 10.09-2.2% | 10.32-6.1% | 10.99-5.6% | 11.64+12.2% | 10.37 |
| Tax | 0.00 | — | — | — | — |
| PROFIT | |||||
| PBT | 8.72+190.4% | -9.65+8.6% | -10.56+0.4% | -10.60-5.8% | -10.02 |
| Net Profit | -7.02+26.1% | -9.50+8.7% | -10.41+0.5% | -10.46-6.2% | -9.85 |
| KEY METRICS | |||||
| OPM % | 50.23%+150.23pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -34.60%+65.39pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -13.60-116.6% | -6.28+38.8% | -10.26+38.6% | -16.70-1490.5% | -1.05 |
Corporate Events
Board MeetingJAGX
20268Jun
Board Meeting
Stockholders approved the election of one Class II director,…
SEC Filing ↗